CMA1 and pulmonary fibrosis: Interestingly, chymase inhibition has been shown to attenuate pulmonary fibrosis by decreasing TGF‐β expression and diminishing chymase‐induced fibroblast proliferation (Kosanovic et al., 2015; Takato et al., 2011; Tomimori et al., 2003).